Dr. Hahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave.
Children's Hospital, Neurology
Boston, MA 02115Phone+1 617-355-8735
Education & Training
- University of Toronto Faculty of MedicineClass of 1990
Clinical Trials
- A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome Start of enrollment: 2022 Mar 04
Roles: Principal Investigator
- A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome Start of enrollment: 2021 Oct 28
Roles: Principal Investigator
- A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome Start of enrollment: 2021 Nov 08
Roles: Principal Investigator
Publications & Presentations
PubMed
- Correction: Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Biospecimens and Biomarkers.Vishank A Shah, H E Hinson, Michael E Reznik, Cecil D Hahn, Sheila Alexander
Neurocritical Care. 2025-02-01 - Correction: Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group in the Pediatric Population.Varina L Boerwinkle, Brian Appavu, Emilio Garzon Cediel, Jennifer Erklaurer, Saptharishi Lalgudi Ganesan
Neurocritical Care. 2025-02-01 - The American Clinical Neurophysiology Society Guideline on Indications for Continuous Electroencephalography Monitoring in Neonates.Courtney J Wusthoff, Adam L Numis, Ronit M Pressler, Catherine J Chu, Shavonne Massey
Journal of Clinical Neurophysiology. 2025-01-01
Press Mentions
- Educational Initiatives for Electroencephalography in the Critical Care Setting: A Systematic Review and Meta-AnalysisMarch 11th, 2021
- L'étude ELEKTRA De Phase 2 Évaluant Le Soticlestat (TAK-935/OV935) Atteint Son Critère Principal De Réduction De La Fréquence Des Crises Chez Les Enfants Atteints Du Syndrome De Dravet Ou Du Syndrome De Lennox-GastautAugust 26th, 2020
- Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint Reducing Seizure Frequency in Children with Dravet Syndrome or Lennox-Gastaut SyndromeAugust 25th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: